Senior Scientist
Salary not available. View on company website.
UK Health Security Agency, East Winterslow, Wiltshire
- Full time
- Permanent
Apply on company site
Posted 1 day ago, 25 Mar
Senior Scientist - Contai...
Salary not available. View on company website.
UK Health Security Agency, Boscombe, Wiltshire
- Full time
- Permanent
Apply on company site
Posted 4 days ago, 22 Mar
Sterile Services Technici...
£23615
Steris Corporation, Harnham, Wiltshire
- Full time
- Permanent
Apply on company site
Posted 1 week ago, 19 Mar
Clinical Fellow (RIPL)
Salary not available. View on company website.
UK Health Security Agency, Idmiston, Wiltshire
- Full time
- Temporary
Apply on company site
Posted 2 weeks ago, 11 Mar
Chemist | THG Labs
Salary not available. View on company website.
THG, Longfield, Wiltshire
- Full time
- Permanent
Apply on company site
Posted 2 weeks ago, 9 Mar
Salary not available. View on company website.
UK Health Security Agency, East Winterslow, Wiltshire
- Onsite working
- Full time
- Permanent
Posted 1 day ago, 25 Mar
Job ref: 19be3ffd706c494f8c3a9a562029e229
Full Job Description
As a Senior Scientist in the Diagnostics, Evaluation and Innovation Team you will provide scientific and technical expertise to deliver improved diagnostics for rare, emerging, difficult to diagnose and high consequence infectious disease agents. The post holder will also have line management responsibilities and provide surge capacity and work within the RIPL laboratory under the direction of qualified Biomedical scientists when needed.
The post holder will have a pivotal role in evaluating commercial assays and transitioning research/developmental assays for rare and difficult to diagnose pathogens into RIPL ensuring compliance with ISO15189:2022 standards and IVDR regulations. They will be expected to learn about the pathogen of interest, research possible diagnostic assays and investigate their utility against the clinical need. These tests may be for the detection of nucleic acids, protein antigens or patient antibodies. These tests must then be evaluated, and if suitable, validated and introduced into the RIPL workflow complete with SOPs, risk assessments, staff training and compliance documentation.
The Research and Evaluation department based at UKHSA Porton has approximately 300 staff, performing a range of research activities, including high containment level work. The department's work covers a broad range of projects involving the development and evaluation of interventions into a range of infectious diseases e.g., SARS-CoV-2, Ebola, Zika, Crimean-Congo Haemorrhagic Fever, Q Fever, Anthrax, Plague, Melioidosis and Monkeypox. The department also has a test facility performing regulated studies in compliance with GLP, GCP and GMP.
This post is part of the Diagnostics Evaluation and Innovation (DEI) team at UKHSA Porton Down. The focus of the DEI team is to review, evaluate, develop, and implement diagnostic assays for the Rare and Imported Pathogens Laboratory (RIPL), the front-line diagnostic laboratory for the detection of the Viral Haemorrhagic Fevers (Ebola, Lassa, CCHF, Marburg), vector-borne viruses, Rickettsiae and biothreat agents including Bacillus anthracis and Francisella tularensis. The DEI team also evaluate diagnostic assays for external stakeholders and broader distribution across the healthcare network in the event of outbreaks and for incident response.
The Diagnostics, Evaluation and Innovation Team reviews, evaluates, develops, and implements diagnostic assays for use in UKHSA/NHS and locally for the Rare and Imported Pathogens Laboratory (RIPL), working with suppliers, commercial partners and academic groups., We pride ourselves as being an employer of choice, where Everyone Matters promoting equality of opportunity to actively encourage applications from everyone, including groups currently underrepresented in our workforce.
UKHSA ethos is to be an inclusive organisation for all our staff and stakeholders. To create, nurture and sustain an inclusive culture, where differences drive innovative solutions to meet the needs of our workforce and wider communities. We do this through celebrating and protecting differences by removing barriers and promoting equity and equality of opportunity for all.
The post holder will have a pivotal role in evaluating commercial assays and transitioning research/developmental assays for rare and difficult to diagnose pathogens into RIPL ensuring compliance with ISO15189:2022 standards and IVDR regulations. They will be expected to learn about the pathogen of interest, research possible diagnostic assays and investigate their utility against the clinical need. These tests may be for the detection of nucleic acids, protein antigens or patient antibodies. These tests must then be evaluated, and if suitable, validated and introduced into the RIPL workflow complete with SOPs, risk assessments, staff training and compliance documentation.
The Research and Evaluation department based at UKHSA Porton has approximately 300 staff, performing a range of research activities, including high containment level work. The department's work covers a broad range of projects involving the development and evaluation of interventions into a range of infectious diseases e.g., SARS-CoV-2, Ebola, Zika, Crimean-Congo Haemorrhagic Fever, Q Fever, Anthrax, Plague, Melioidosis and Monkeypox. The department also has a test facility performing regulated studies in compliance with GLP, GCP and GMP.
This post is part of the Diagnostics Evaluation and Innovation (DEI) team at UKHSA Porton Down. The focus of the DEI team is to review, evaluate, develop, and implement diagnostic assays for the Rare and Imported Pathogens Laboratory (RIPL), the front-line diagnostic laboratory for the detection of the Viral Haemorrhagic Fevers (Ebola, Lassa, CCHF, Marburg), vector-borne viruses, Rickettsiae and biothreat agents including Bacillus anthracis and Francisella tularensis. The DEI team also evaluate diagnostic assays for external stakeholders and broader distribution across the healthcare network in the event of outbreaks and for incident response.
The Diagnostics, Evaluation and Innovation Team reviews, evaluates, develops, and implements diagnostic assays for use in UKHSA/NHS and locally for the Rare and Imported Pathogens Laboratory (RIPL), working with suppliers, commercial partners and academic groups., We pride ourselves as being an employer of choice, where Everyone Matters promoting equality of opportunity to actively encourage applications from everyone, including groups currently underrepresented in our workforce.
UKHSA ethos is to be an inclusive organisation for all our staff and stakeholders. To create, nurture and sustain an inclusive culture, where differences drive innovative solutions to meet the needs of our workforce and wider communities. We do this through celebrating and protecting differences by removing barriers and promoting equity and equality of opportunity for all.
Copy the direct link to this job
www.jobs24.co.uk/job/senior-scientist-124818831